Harold Katner

Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study

Chloe Orkin, Enrique Bernal, Darrell H. S. Tan et al. · The Lancet HIV · 2021 · 136 citations

Treatment And Prevention, Medicine, Antiviral Drug Development +10

Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia

Seth C. Kalichman, Lisa A. Eaton, Marcie Berman et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 82 citations · Full text

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

Miranda Murray, Antonio Antela, Anthony Mills et al. · AIDS and Behavior · 2020 · 76 citations · Full text

Patient-reported Outcomes, Week 48, Rilpivirine Over 48 +21

Students Together Against Negative Decisions (STAND): Evaluation of a School-Based Sexual Risk Reduction Intervention in the Rural South

Mike U. Smith, Francis C. Dane, Randolph S. Devereaux et al. · AIDS Education and Prevention · 2000 · 68 citations

Population Density and AIDS-Related Stigma in Large-Urban, Small-Urban, and Rural Communities of the Southeastern USA

Seth C. Kalichman, Harold Katner, Ellen Banas et al. · Prevention Science · 2017 · 63 citations

Social Stigma, Southeastern Usa, Stigmatization +14